1 ml per vial
Sponsors
Suzhou Ribo Life Science Co. Ltd., Sun Pharmaceutical Industries Limited
Conditions
Chronic hepatitis BType 2 diabetes mellitus
Phase 2
A phase II clinical trial to evaluate the safety, efficacy, and pharmacokinetics of RBD1016 injection in participants with chronic hepatitis B
CompletedCTIS2023-503880-40-00
Start: 2023-09-19End: 2025-10-15Target: 24Updated: 2025-06-11
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once Weekly s.c. Administered GL0034 in Adults with Type 2 Diabetes Mellitus Inadequately controlled on Metformin Or Diet and Exercise
Active, not recruitingCTIS2024-513279-41-00
Start: 2024-09-06Target: 60Updated: 2025-11-10